Matinas Biopharma Holdings, Inc

Historical 13F Holders

Symbol
MTNB
CUSIP
576810303
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 576810303 since 12/18/2024, newest first.

Filer % of Class Filed
Sanitam Partners LLC 13D/A Amendment 2
10.0% 8/13/2026
Event 6/10/2026
Hezbay Holdings LLC 13G 9.5% 7/14/2026
Event 7/13/2026
Highbridge Capital Management LLC 13G/A Amendment 2 0% 11/14/2025
Event 9/30/2025
Hezbay Holdings LLC 13D/A Amendment 2
4.99% 9/25/2025
Event 9/25/2025
Lazar David E. 13G 9.8% 8/19/2025
Event 8/15/2025
Highbridge Capital Management, LLC 13G/A Amendment 1 8.4% 8/14/2025
Event 6/30/2025
Sanitam Partners LLC 13D/A Amendment 1
10.0% 4/10/2025
Event 4/8/2025
Pembroke & Partners LLC 13D/A Amendment 1
10.0% 4/10/2025
Event 4/8/2025
Pembroke & Partners LLC 13D
20.0% 2/21/2025
Event 2/13/2025
Sanitam Partners LLC 13D
24.1% 2/21/2025
Event 2/13/2025
111 Equity Group 13D/A Amendment 1
3.6% 2/19/2025
Event 2/13/2025
111 Equity Group 13D
5.2% 1/6/2025
Event 1/2/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 25 325 k $199 k
2026 Q1 28 354 k $177 k
2025 Q4 30 442 k $260 k
2025 Q3 28 330 k $618 k
2025 Q2 26 276 k $254 k
2025 Q1 26 320 k $166 k
2024 Q4 23 370 k $194 k
2024 Q3 19 546 k $1.90 M